The global apoptosis regulator BAX market is anticipated to grow at a significant CAGR of 6.2% during the forecast period 2022-2028. Apoptosis regulator BAX is also known as BCL-2-like protein 4. The BAX gene in humans codes for a protein called BAX. BAX is also a member of the Bcl-2 gene family, which forms hetero- or homodimers and functions as anti- or pro-apoptotic regulators in a range of cellular processes. The rising prevalence of liver cancer throughout the globe is one of the primary factors driving market growth. According to the WHO, liver cancer is the sixth most prevalent type of cancer globally with 905.7 thousand new cases registered in 2020 and 830.2 thousand people had died due to this cancer. BAX is a primary cell death regulator and a key regulator of the apoptosis intrinsic pathway in the cancer treatment. It also regulates apoptosis in both normal and malignant cells. As a result, the need for the apoptotic regulator BAX is increasing due to the rising occurrence of liver cancer.
Impact of COVID-19 on Global Apoptosis Regulator BAX Market
The COVID-19 had a significantly impacted the global apoptosis regulator BAX market. As liver cancer is the major factor attributing to the growth of the market, due to the implication of stringent lockdowns, there was a delay in diagnosis of various types of cancers globally. As the COVID-19 situation got normalized, the demand for apoptosis regulator BAX had increased as the backlog treatment of had started in hospitals, which had boosted the market growth of apoptosis regulator BAX significantly.
Segmental Outlook
The global apoptosis regulator BAX market is segmented based on type and application. Based on the type, the market is sub-segmented into GM-6, HU-010, LTX-401, and others. Based on the application, the market is sub-segmented into liver cancer, stroke, melanoma, Parkinson’s disease, and others. The segments mentioned above can also be customized as per requirements. The liver cancer segment holds a prominent share in the market due to the increasing cases of liver cancer globally.
Global Apoptosis Regulator BAX Market Share by Application, 2021 (%)
The Liver Cancer Segment is Anticipated to Hold a Prominent Share in the Global Apoptosis Regulator BAX Market
The liver cancer segment holds a prominent share in the market due to higher prevalence globally. The American Cancer Society had predicted 41,260 additional cases of liver cancer will be detected in the US alone during 2022. As a result of which the demand for apoptosis regulator BAX will also increase significantly. Therefore, the liver cancer segment will hold a significant share in the market. The melanoma segment is expected to grow fastest during the forecast period due to the rising pollution and increasing usage of chemicals in the production of human meal, which is a major cause of melanoma prevalence globally.
Regional Outlooks
The global apoptosis regulator BAX market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. During the projection period, North America is expected to see significant market expansion, due to the increasing cases of liver cancer in the US and the presence of key pharmaceutical companies investing in the research and development activities.
Global Apoptosis Regulator BAX Market Growth, by Region 2022-2028
The North America Region is anticipated to Hold the Major Share in the Global Apoptosis Regulator BAX Market
The North America region dominates the global apoptosis regulator BAX market. The region's dominance is attributable to the growth on number of cases of liver cancer. It is predicted by the American Cancer Society that around 41,260 new cases (28,600 in men and 12,660 in women) will be diagnosed in the US during 2022 and about 30,520 people (20,420 men and 10,100 women) will die from these cancer.
The Asia-Pacific and Africa regions are expected to grow fastest in the market as liver cancer is much more common in countries in sub-Saharan Africa and Southeast Asia than in the US; however, remains undiagnosed due to lack of resources and awareness. In many of these countries, it is the most common type of cancer. With the rising public awareness for timely diagnosis and growing per capita income will drive the market of apoptosis regulator BAX in these regions during the forecast period.
Market Players Outlook
Genervon Biopharmaceuticals LLC, Lytix Biopharma AS, and Huons Co. Ltd., among others. are some of the market's leading participants. To stay competitive in the market, industry players are using a variety of tactics such as mergers and acquisitions, regional expansion, partnerships and collaborations, and new product releases to contribute substantially to market growth. For instance, in July 2021, Ipsen Pharma had partnered with BAKX Therapeutics Inc. to research, develop, manufacture and commercialize BKX-001 as a potential treatment for leukemia, lymphoma and solid tumors.
The Report Covers
1.Report Summary
1.1.Research Methods and Tools
1.2.Market Breakdown
1.2.1.By Segments
1.2.2.BY Region
2.Market Overview and Insights
2.1.Scope of the Report
2.2.Analyst Insight & Current Market Trends
2.2.1.Key Findings
2.2.2.Recommendations
2.2.3.Conclusion
3.Competitive Landscape
3.1Lytix Biopharma AS
3.1.1.Overview
3.1.2.Financial Analysis
3.1.3.SWOT Analysis
3.1.4.Recent Developments
3.2.PHD Biosciences Inc.
3.2.1.Overview
3.2.2.Financial Analysis
3.2.3.SWOT Analysis
3.2.4.Recent Developments
3.3.Pfizer Inc.
3.3.1.Overview
3.3.2.Financial Analysis
3.3.3.SWOT Analysis
3.3.4.Recent Developments
3.4.Key Strategy Analysis
3.5.Impact of Covid-19 on Key Players
4.Market Segmentation
4.1.Global Apoptosis Regulator BAX Market by Type
4.1.1.GM-6
4.1.2.HU-010
4.1.3.LTX-401
4.1.4.Others
4.2.Global Apoptosis Regulator BAX Market by Application
4.2.1.Liver Cancer
4.2.2.Stroke
4.2.3.Melanoma
4.2.4.Parkinson’s Disease
4.2.5.Others
5.Regional Analysis
5.1.North America
5.1.1.United States
5.1.2.Canada
5.2.Europe
5.2.1.UK
5.2.2.Germany
5.2.3.Italy
5.2.4.Spain
5.2.5.France
5.2.6.Rest of Europe
5.3.Asia-Pacific
5.3.1.China
5.3.2.India
5.3.3.Japan
5.3.4.Rest of Asia-Pacific
5.4.Rest of the World
6.Company Profiles
6.1.Genervon Biopharmaceuticals LLC
6.2.Huons Co. Ltd.
6.3.Plexxicon Inc.
6.4.Proximagen Ltd.
6.5.Rottapharm Biotech Srl
6.6.Sienna Biopharmaceuticals Inc.
6.7.Tiziana Life Sciences PLC
1.GLOBAL APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2.GLOBAL GM-6 APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3.GLOBAL HU-010 APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4.GLOBAL LTX-401 APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5.GLOBAL OTHERS APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6.GLOBAL APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
7.GLOBAL LIVER CANCER APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8.GLOBAL STROKE APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9.GLOBAL MELANOMA APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10.GLOBAL PARKINSON’S DISEASE APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11.GLOBAL OTHERS APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12.GLOBAL APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
13.NORTH AMERICAN APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
14.NORTH AMERICAN APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
15.NORTH AMERICAN APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
16.EUROPEAN APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
17.EUROPEAN APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
18.EUROPEAN APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
19.ASIA-PACIFIC APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
20.ASIA-PACIFIC APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
21.ASIA-PACIFIC APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
22.REST OF THE WORLD APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
23.REST OF THE WORLD APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
24.REST OF THE WORLD APOPTOSIS REGULATOR BAX MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1.IMPACT OF COVID-19 ON GLOBAL APOPTOSIS REGULATOR BAX MARKET, 2021-2028 ($ MILLION)
2.IMPACT OF COVID-19 ON GLOBAL APOPTOSIS REGULATOR BAX MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3.RECOVERY OF GLOBAL APOPTOSIS REGULATOR BAX MARKET, 2021-2028 (%)
4.GLOBAL APOPTOSIS REGULATOR BAX MARKET SHARE BY TYPE, 2021 VS 2027 (%)
5.GLOBAL GM-6 APOPTOSIS REGULATOR BAX MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6.GLOBAL HU-010 APOPTOSIS REGULATOR BAX MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7.GLOBAL LTX-401 APOPTOSIS REGULATOR BAX MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8.GLOBAL OTHERS APOPTOSIS REGULATOR BAX MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9.GLOBAL APOPTOSIS REGULATOR BAX MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
10.GLOBAL LIVER CANCER APOPTOSIS REGULATOR BAX MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11.GLOBAL STROKE APOPTOSIS REGULATOR BAX MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12.GLOBAL MELANOMA APOPTOSIS REGULATOR BAX MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13.GLOBAL PARKINSON’S DISEASE APOPTOSIS REGULATOR BAX MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14.GLOBAL OTHERS APOPTOSIS REGULATOR BAX MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15.GLOBAL APOPTOSIS REGULATOR BAX MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16.US APOPTOSIS REGULATOR BAX MARKET SIZE, 2021-2028 ($ MILLION)
17.CANADA APOPTOSIS REGULATOR BAX MARKET SIZE, 2021-2028 ($ MILLION)
18.UK APOPTOSIS REGULATOR BAX MARKET SIZE, 2021-2028 ($ MILLION)
19.FRANCE APOPTOSIS REGULATOR BAX MARKET SIZE, 2021-2028 ($ MILLION)
20.GERMANY APOPTOSIS REGULATOR BAX MARKET SIZE, 2021-2028 ($ MILLION)
21.ITALY APOPTOSIS REGULATOR BAX MARKET SIZE, 2021-2028 ($ MILLION)
22.SPAIN APOPTOSIS REGULATOR BAX MARKET SIZE, 2021-2028 ($ MILLION)
23.REST OF EUROPE APOPTOSIS REGULATOR BAX MARKET SIZE, 2021-2028 ($ MILLION)
24.INDIA APOPTOSIS REGULATOR BAX MARKET SIZE, 2021-2028 ($ MILLION)
25.CHINA APOPTOSIS REGULATOR BAX MARKET SIZE, 2021-2028 ($ MILLION)
26.JAPAN APOPTOSIS REGULATOR BAX MARKET SIZE, 2021-2028 ($ MILLION)
27.REST OF THE ASIA-PACIFIC APOPTOSIS REGULATOR BAX MARKET SIZE, 2021-2028 ($ MILLION)
28.REST OF THE WORLD APOPTOSIS REGULATOR BAX MARKET SIZE, 2021-2028 ($ MILLION)